Clinical Trial Update: To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability trial of aztreonam-avibactam (ATM-AVI) in complicated infections has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Complicated Infection

Drugs mentioned

• Aztreonam-avibactam (Aztreonam + Avibactam)

Snippet

Sponsor: Pfizer | Conditions: Complicated Infection, Bacterial Infections | Phase 1 | Status: COMPLETED | Results posted: 2016-10-26